BioMarin Pharmaceutical Inc. buy Bank of America Co.
Start price
19.05.26
/
50%
€42.92
Target price
19.05.27
€68.72
Performance (%)
11.23%
Price
18.06.26
€47.74
Summary
This prediction is currently active. The BUY prediction by Bank_of_America_Co_ currently has a performance of 11.23%. This prediction currently runs until 19.05.27. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| BioMarin Pharmaceutical Inc. | -0.438% |
| iShares Core DAX® | 1.750% |
| iShares Nasdaq 100 | 4.301% |
| iShares Nikkei 225® | 9.895% |
| iShares S&P 500 | 2.542% |
Comments by Bank_of_America_Co_ for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical (BMRN) had its price target lowered by Bank of America Corporation from $85.00 to $80.00. They now have a "buy" rating on the stock.
Ratings data for BMRN provided by MarketBeat
Stopped prediction by Bank_of_America_Co_ for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€52.12
11.03.26
11.03.26
€73.15
11.03.27
11.03.27
-8.40%
18.06.26
18.06.26
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€68.34
20.02.25
20.02.25
€98.56
20.02.26
20.02.26
-21.69%
21.02.26
21.02.26
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€62.80
17.09.24
17.09.24
€103.34
17.09.25
17.09.25
-26.54%
18.09.25
18.09.25